Holen Sie sich die Stockscreener-App
11.11
2.54%
-0.29
Handel nachbörslich:
11.14
0.03
+0.27%
Schlusskurs vom Vortag:
$11.40
Offen:
$11.26
24-Stunden-Volumen:
152.31K
Relative Volume:
0.13
Marktkapitalisierung:
$744.20M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-103.21M
KGV:
-2.4152
EPS:
-4.6001
Netto-Cashflow:
$-26.70M
1W Leistung:
+22.09%
1M Leistung:
+16.95%
6M Leistung:
+200.27%
1J Leistung:
+64.11%
1-Tages-Spanne:
$10.96
$11.61
1-Wochen-Bereich:
$9.01
$12.25
52-Wochen-Spanne:
$2.65
$12.25
Engene Holdings Inc Stock (ENGN) Company Profile
Firmenname
Engene Holdings Inc
Sektor
Branche
Telefon
(514) 332-4888
Adresse
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
Vergleichen Sie ENGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENGN
Engene Holdings Inc
|
11.11 | 763.63M | 0 | -103.21M | -26.70M | -4.6001 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-02-18 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-14 | Herabstufung | UBS | Buy → Neutral |
| 2024-12-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-11-27 | Eingeleitet | Raymond James | Outperform |
| 2024-11-18 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-08-28 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-04-15 | Eingeleitet | Guggenheim | Buy |
| 2024-03-28 | Eingeleitet | UBS | Buy |
| 2024-03-08 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-20 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Engene Holdings Inc Aktie (ENGN) Neueste Nachrichten
enGene: Two Major Catalysts On Deck For 2nd Half Of 2026 (NASDAQ:ENGN) - Seeking Alpha
enGene Holdings Closes $130 Million Public Offering - MSN
EnGene extends momentum with another 14% surge on Friday - MSN
Trend Recap: Is HBTA a cyclical or defensive stockMarket Growth Review & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Short Squeeze: Is enGene Holdings Inc stock a good dividend stockJuly 2025 Big Picture & High Accuracy Investment Signals - baoquankhu1.vn
enGene extends momentum with another 14% surge on Friday (ENGN:NASDAQ) - Seeking Alpha
enGene (NASDAQ:ENGN) Hits New 1-Year HighStill a Buy? - MarketBeat
Profit Recap: What analysts say about enGene Holdings Inc Equity Warrant stockPortfolio Risk Summary & Capital Efficiency Focused Strategies - baoquankhu1.vn
enGene (NASDAQ:ENGN) Stock Price Up 11.3%Time to Buy? - MarketBeat
Aug Reactions: Is Heritage Financial Corporation a speculative investmentWeekly Risk Summary & Expert Approved Momentum Ideas - baoquankhu1.vn
enGene (NASDAQ:ENGN) Sees Strong Trading VolumeWhat's Next? - MarketBeat
enGene Holdings (NASDAQ: ENGN) adds $125M debt facility and new warrants - Stock Titan
Breakout Watch: Is enGene Holdings Inc. benefiting from interest rate changesJuly 2025 EndofMonth & Verified Swing Trading Watchlist - baoquankhu1.vn
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc. - PharmiWeb.com
Weekly Trades: Does enGene Holdings Inc Equity Warrant stock benefit from AI growth2025 Macro Impact & Safe Swing Trade Setup Alerts - baoquankhu1.vn
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital - citybiz
enGene Holdings Secures $125 Million Loan Agreement with Hercules Capital - Intellectia AI
Meme Stocks: Is enGene Holdings Inc benefiting from interest rate changesJuly 2025 Rallies & Verified Entry Point Signals - baoquankhu1.vn
Is enGene Holdings Inc. a strong growth stockPortfolio Allocation Tips & Free Tap Rapid Wealth - bollywoodhelpline.com
Targets Report: Will HITI benefit from geopolitical trendsQuarterly Market Review & Safe Capital Preservation Plans - baoquankhu1.vn
enGene Holdings Inc. (NASDAQ:ENGN) Short Interest Up 32.4% in December - MarketBeat
Aug Summary: Will PCRX announce a stock splitAnalyst Downgrade & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Portfolio Update: Can enGene Holdings Inc benefit from deglobalizationJuly 2025 PostEarnings & Risk Managed Trade Strategies - baoquankhu1.vn
AI Stocks: What drives enGene Holdings Inc Equity Warrants stock price2025 Historical Comparison & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Quarterly Recap: Is enGene Holdings Inc benefiting from interest rate changesQuarterly Portfolio Report & High Return Stock Watch Alerts - baoquankhu1.vn
enGene (NASDAQ:ENGN) Sees Large Volume IncreaseStill a Buy? - MarketBeat
Does enGene Holdings Inc outperform in volatile markets2025 Year in Review & Growth Focused Entry Reports - baoquankhu1.vn
Growth Report: Is enGene Holdings Inc Equity Warrant impacted by rising ratesTrade Risk Assessment & Real-Time Stock Entry Alerts - baoquankhu1.vn
Stock Market Recap: What analysts say about ACON stockTrade Performance Summary & Free High Return Stock Watch Alerts - baoquankhu1.vn
How resilient is enGene Holdings Inc. Equity Warrant stock in market downturnsJuly 2025 Reactions & Weekly High Potential Alerts - Улправда
enGene Holdings Inc. (NASDAQ:ENGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Short Covering: Is enGene Holdings Inc. Equity Warrant stock a dividend growth opportunity2025 Growth vs Value & Community Trade Idea Sharing - Улправда
Aug Highlights: Can enGene Holdings Inc Equity Warrant stock sustain free cash flow growth2025 Pullback Review & Consistent Income Trade Recommendations - Bộ Nội Vụ
Can enGene Holdings Inc. stock double in next 5 yearsNew Guidance & Safe Entry Momentum Stock Tips - Улправда
How enGene Holdings Inc. stock performs in high volatility markets2025 Price Targets & Weekly High Potential Stock Alerts - ulpravda.ru
How geopolitical tensions affect enGene Holdings Inc. Equity Warrant stockQuarterly Market Summary & High Yield Stock Recommendations - Улправда
Is enGene Holdings Inc. Equity Warrant stock a dividend growth opportunityTrade Performance Summary & Growth-Oriented Investment Plans - Улправда
Will enGene Holdings Inc. stock benefit from AI adoption2025 Price Momentum & Daily Stock Trend Watchlist - ulpravda.ru
Is enGene Holdings Inc. stock safe for conservative investorsJuly 2025 Gainers & Reliable Price Action Trade Plans - Улправда
Is enGene Holdings Inc. stock a contrarian buy2025 Retail Activity & Consistent Income Trade Recommendations - Улправда
Operating cash flow per share of enGene Holdings Inc. Warranton enGene Holdings – NASDAQ:ENGNW - TradingView — Track All Markets
enGene (NASDAQ:ENGN) Stock Price Up 7%Still a Buy? - MarketBeat
enGene Holdings Inc Stock Analysis and ForecastValue Traps to Avoid & Hidden Gems with Outstanding Profit Margins - earlytimes.in
Citizens reiterates Market Outperform rating on Engene stock with $21 target - Investing.com Nigeria
Citizens reiterates Market Outperform rating on Engene stock with $21 target By Investing.com - Investing.com South Africa
Piper Sandler Initiates Coverage of enGene Holdings (ENGN) with Overweight Recommendation - MSN
enGene (NASDAQ:ENGN) Shares Gap Up – Should You Buy? - Defense World
enGene (NASDAQ:ENGN) Shares Gap UpStill a Buy? - MarketBeat
enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN) - Seeking Alpha
ETFs Investing in enGene Holdings Inc. Stocks - TradingView — Track All Markets
While Institutions Invested in EnGene Holdings Inc. (NASDAQ:ENGN) Benefited From Last Week's 21% Gain, Private Equity Firms Stood to Gain the Most - 富途牛牛
Finanzdaten der Engene Holdings Inc-Aktie (ENGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):